Search results for "Oxindole"

showing 10 items of 31 documents

Roxindole, a dopamine autoreceptor agonist, in the treatment of major depression

1993

Roxindole is a potent autoreceptor-“selective” dopamine agonist originally developed for the treatment of schizophrenic syndromes. The drug also inhibits 5-HT uptake and has 5-HT1A agonistic actions. In this open clinical trial 12 in-patients suffering from a major depressive episode (DSM-III-R) were treated with roxindole for 28 days in a fixed dosage of 15 mg per day. A reduction of at least 50% in HAMD-17 total scores was observed in 8 out of 12 patients after 4 weeks (mean HAMD-17 reduction of 56% in all patients), while 4 patients did not respond to roxindole treatment. Half of the patients showed a complete psychopathological remission (HAMD-17 <8). Roxindole's onset of antidepressant…

AdultMaleAgonistIndolesPyridinesmedicine.drug_classPharmacologyDopamine agonistAsymptomaticchemistry.chemical_compoundRoxindoleDopaminemedicineHumansPharmacology (medical)Major depressive episodePsychiatric Status Rating ScalesPharmacologyDepressive Disorderbusiness.industryMiddle AgedOxindolesProlactinchemistryDopamine receptorAnesthesiaDopamine AgonistsAutoreceptorAntidepressantFemaleNeurology (clinical)medicine.symptombusinessPsychologymedicine.drugPsychopharmacology
researchProduct

Stereoselective Synthesis of Spiro-Decalin Oxindole Derivatives via Sequential Organocatalytic Michael-Domino Michael/Aldol Reaction.

2022

A highly stereoselective procedure for the synthesis of spiro-polycyclic oxindoles bearing five contiguous stereogenic centers including two tetrasubstituted carbons has been developed. Under sequential organocatalysis performed by a pyrrolidine-based organocatalyst and DBU, a highly atom-economical Michael–domino Michael/aldol reaction sequence was optimized, yielding variously functionalized spiro-decalin oxindoles with excellent stereoselectivity (>99:1 dr, up to 92% ee). peerReviewed

kemiallinen synteesiAldehydesMolecular StructureOrganic Chemistryasymmetric organocatalysisdomino reactionssprio heterocyclesStereoisomerismNaphthalenesCatalysisOxindolesorgaaninen kemiaSpiro Compoundsasymmetric organocatalysis; oxindoles; sprio heterocycles; domino reactionsThe Journal of organic chemistry
researchProduct

Control of N-Heterocyclic Carbene Catalyzed Reactions of Enals: Asymmetric Synthesis of Oxindole-γ-Amino Acid Derivatives.

2017

A strategy to control the switch between a non‐cycloaddition reaction and a cycloaddition reaction of enals, using N‐heterocyclic carbene (NHC) catalyisis, has been developed. The new scalable protocol leads to γ‐amino‐acid esters bearing a tetrasubstituted stereocenter in good yields and high stereoselectivities by homo‐Mannich reactions of enals and isatin‐derived ketimines. By simply changing the N‐ketimine substituent to an ortho‐hydroxy phenyl group, the corresponding spirocyclic oxindolo‐γ‐lactams are obtained. peerReviewed

StereochemistrySubstituent010402 general chemistry01 natural sciencesCatalysisStereocenterCatalysischemistry.chemical_compoundaldehyditaldehydesPhenyl groupOxindoleta116orgaaniset yhdisteetkemiallinen synteesi010405 organic chemistryEnantioselective synthesisGeneral MedicineGeneral ChemistryCycloaddition0104 chemical scienceschemistryorganic compoundsCarbenechemical synthesisAngewandte Chemie (International ed. in English)
researchProduct

Design, Construction, and Characterization of a New Regioisomer and Diastereomer Material Based on the Spirooxindole Scaffold Incorporating a Sulphon…

2020

The 1,3-dipolar cycloaddition reaction is one of the most rapid, and efficient protocols to access, and construct highly divergent heterocycle chiral auxiliaries. Free catalyst synthesis of spirooxindole scaffold incorporating sulphone moiety via one pot&ndash

aromaattiset yhdisteetPhysics and Astronomy (miscellaneous)isomeriaGeneral Mathematics13-dipolar cycloaddition reaction010402 general chemistry01 natural sciencesdiastereomerComputational chemistrysulphonerikkiyhdisteetComputer Science (miscellaneous)MoietyReactivity (chemistry)Molecular orbitalHOMO/LUMOorgaaniset yhdisteet010405 organic chemistryChemistrylcsh:MathematicsChemical shiftDiastereomerspirooxindoleHirshfeld analysislcsh:QA1-939Cycloaddition0104 chemical sciencesregioisomerChemistry (miscellaneous)Natural bond orbitalSymmetry
researchProduct

A DFT study of the mechanism and selectivities of the [3 + 2] cycloaddition reaction between 3-(benzylideneamino)oxindole and trans -β-nitrostyrene

2016

The mechanism and regioselectivities and stereoselectivities of the [3 + 2] cycloaddition (32CA) reaction of 3-(benzylideneamino) oxindole (AY) and trans-β-nitrostyrene have been studied using both B3LYP and ωB97XD density functional theory methods together with the standard 6-31G(d) basis set. Four reactive pathways associated with the ortho and meta regioselective channels and endo and exo stereoselective approaches modes have been explored and characterized. While the B3LYP functional fails to predict the experimental regioselectivity, the ωB97XD one succeeds to predict the experimentally observed meta regioselectivity favoring the formation of meta/endo cycloadduct as the major isomer. …

Reaction mechanism010405 organic chemistryChemistryStereochemistryOrganic ChemistryRegioselectivityAzomethine ylide010402 general chemistry01 natural sciencesCycloaddition0104 chemical scienceschemistry.chemical_compoundStereoselectivityReactivity (chemistry)OxindolePhysical and Theoretical ChemistrySolvent effectsJournal of Physical Organic Chemistry
researchProduct

Catalytic Enantioselective Addition of Me2Zn to Isatins

2017

Chiral α-hydroxyamide L5 derived from (S)-(+)-mandelic acid catalyzes the enantioselective addition of dimethylzinc to isatins affording the corresponding chiral 3-hydroxy-3-methyl-2-oxindoles with good yields and er up to 90:10. Furthermore, several chemical transformations were performed with the 3-hydroxy-2-oxindoles obtained.

Dimethylzincchemistry.chemical_elementZinc010402 general chemistrylcsh:Chemical technology01 natural sciencesisatinCatalysisCatalysislcsh:Chemistrychemistry.chemical_compoundchiral α-hydroxyamide3-hydroxyoxindoleCatàlisilcsh:TP1-1185Physical and Theoretical Chemistry010405 organic chemistryChemistryIsatinzincEnantioselective synthesisasymmetric catalysisCombinatorial chemistry0104 chemical scienceslcsh:QD1-999mandelamidesQuímica orgànica
researchProduct

Synthesis, Characterization, and Cytotoxicity of New Spirooxindoles Engrafted Furan Structural Motif as a Potential Anticancer Agent

2022

A new series of spirooxindoles based on ethylene derivatives having furan aryl moiety are reported. The new hybrids were achieved via [3 + 2] cycloaddition reaction as an economic one-step efficient approach. The final constructed spirooxindoles have four contiguous asymmetric carbon centers. The structure of 3a is exclusively confirmed using X-ray single crystal diffraction. The supramolecular structure of 3a is controlled by O···H, H···H, and C···C intermolecular contacts. It includes layered molecules interconnected weak C–H···O (2.675 Å), H···H (2.269 Å), and relatively short Cl···Br interhalogen interactions [3.4500(11)Å]. Using Hirshfeld analysis, the percentages of these intermolecul…

kemiallinen synteesisyöpäsolutbioaktiiviset yhdisteetGeneral Chemical EngineeringspirooxindolesGeneral ChemistryHirshfeld analysisheterosykliset yhdisteet
researchProduct

Molecular modeling approaches in the discovery of new drugs for anti-cancer therapy: the investigation of p53-MDM2 interaction and its inhibition by …

2010

The mdm2 oncogene product, MDM2, is an ubiquitin protein ligase that inhibits the transcriptional activity of the tumor suppressor p53 and promotes its degradation. About 50% of all human cancers present mutations or deletions in the TP53 gene. In the remaining half of all human neoplasias that express the wild-type protein, aberrations of p53 regula- tors, such as MDM2, account for p53 inhibition. For this reason, designing small-molecule inhibitors of the p53-MDM2 protein-protein interaction is a promising strategy for the treatment of cancers retaining wild-type p53. The development of inhibitors has been challenging. Although many small-molecule MDM2 inhibitors have shown potent in vitr…

IndolesTumor suppressor geneAntineoplastic AgentsMolecular Dynamics SimulationBioinformaticsBiochemistryGene productNeoplasmsDrug DiscoverymedicineHumansImidazolinesMolecular Modeling New Drugs for Anti-Cancer Therapy p53-MDM2 InteractionPharmacologyBenzodiazepinonesbiologyOncogeneOrganic ChemistryCancerProto-Oncogene Proteins c-mdm2medicine.diseaseSettore CHIM/08 - Chimica FarmaceuticaSmall moleculeUbiquitin ligaseOxindolesProtein Structure TertiaryDrug Designbiology.proteinCancer researchMolecular MedicineMdm2PharmacophoreTumor Suppressor Protein p53Current medicinal chemistry
researchProduct

Scandium-catalyzed preparation of cytotoxic 3-functionalized quinolin-2-ones: Regioselective ring enlargement of isatins or imino isatins

2012

Trimethylsilyldiazomethane in the presence of catalytic amounts of Sc(OTf) 3 smoothly promotes the ring expansion of isatins or imino isatins to efficiently afford 3-functionalized quinolin-2-ones through controlled ring enlargement. Whereas the ring-expansion reaction of azetidine-2,3-diones led to the adduct resulting from migration of the carbonyl group, the ring-expansion reaction of oxindole derivatives gave the adduct resulting from migration of the aryl group. To rationalize the experimental observations, theoretical studies have been performed. Moreover, the biological activity of some of the synthesized heterocycles has been evaluated in four cancer cell lines. © 2012 Wiley-VCH Ver…

chemistry.chemical_compoundChemistryStereochemistryArylRegioselectivityHomogeneous catalysisOxindoleGeneral ChemistryTrimethylsilyldiazomethaneRing (chemistry)Medicinal chemistryAdductCatalysis
researchProduct

Roxindole, a dopamine autoreceptor agonist, in the treatment of positive and negative schizophrenic symptoms

1994

Twenty schizophrenic inpatients with either predominantly positive or predominantly negative symptoms were treated with the dopamine autoreceptor agonist roxindole in prospective open clinical trials. There was no antipsychotic effect in the subgroup with positive symptoms, whereas the subgroup with negative symptoms, especially those with the residual type of schizophrenia, showed a moderate but significant 20% reduction in total scores on the Scale for the Assessment of Negative Symptoms.

Agonistmedicine.medical_specialtyPsychosismedicine.drug_classDopamine AgentsGastroenterologyReceptors Dopaminechemistry.chemical_compoundRoxindoleInternal medicinemental disordersSchizophrenic PsychologymedicineHumansProspective StudiesScale for the Assessment of Negative SymptomsPsychiatric Status Rating ScalesSchizophrenia ParanoidDose-Response Relationship Drugbusiness.industrymedicine.diseaseHospitalizationPsychiatry and Mental healthTreatment OutcomeEndocrinologychemistrySchizophreniaDopamine receptorSchizophreniaAutoreceptorSchizophrenic PsychologybusinessAmerican Journal of Psychiatry
researchProduct